<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="correction"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">BMC Psychiatry</journal-id><journal-title-group><journal-title>BMC Psychiatry</journal-title></journal-title-group><issn pub-type="epub">1471-244X</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25927447</article-id><article-id pub-id-type="pmc">4260377</article-id><article-id pub-id-type="publisher-id">313</article-id><article-id pub-id-type="doi">10.1186/s12888-014-0313-9</article-id><article-categories><subj-group subj-group-type="heading"><subject>Erratum</subject></subj-group></article-categories><title-group><article-title>Erratum: A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Katagiri</surname><given-names>Hideaki</given-names></name><address><email>katagiri_hideaki@lilly.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Fujikoshi</surname><given-names>Shinji</given-names></name><address><email>fujikoshi_shinji@lilly.com</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name><surname>Suzuki</surname><given-names>Takuya</given-names></name><address><email>takuya-s@pop01.odn.ne.jp</email></address><xref ref-type="aff" rid="Aff2"/></contrib><contrib contrib-type="author"><name><surname>Fujita</surname><given-names>Kiyoshi</given-names></name><address><email>kiyoshif@rg8.so-net.ne.jp</email></address><xref ref-type="aff" rid="Aff3"/></contrib><contrib contrib-type="author"><name><surname>Sugiyama</surname><given-names>Naoya</given-names></name><address><email>naoyasug@numazuchuo.jp</email></address><xref ref-type="aff" rid="Aff4"/></contrib><contrib contrib-type="author"><name><surname>Takahashi</surname><given-names>Michihiro</given-names></name><address><email>takahashi_michihiro@lilly.com</email></address><xref ref-type="aff" rid="Aff1"/><xref ref-type="aff" rid="Aff6"/></contrib><contrib contrib-type="author"><name><surname>Gomez</surname><given-names>Juan-Carlos</given-names></name><address><email>gomez_juan-carlos@lilly.com</email></address><xref ref-type="aff" rid="Aff5"/></contrib><aff id="Aff1"><label/>Lilly Research Laboratories Japan, Eli Lilly Japan K.K, Kobe, Japan </aff><aff id="Aff2"><label/>Ayase Hospital, 6-3-1 Ayase, Adachi-ku, Tokyo, 120-0005 Japan </aff><aff id="Aff3"><label/>Seishinkai Okehazama Hospital Fujita Kokoro Care Center, 3-879 Sakaecho Minamiyakata, Toyoake-shi, Aichi 470-1168 Japan </aff><aff id="Aff4"><label/>Numazu Chuo Hospital, 24-1 Nakasecho, Numazu-shi, Shizuoka 410-0811 Japan </aff><aff id="Aff5"><label/>Lilly Research Laboratories, Lilly Corporate Center, Indianapolis, IN 46285 USA </aff><aff id="Aff6"><label/>Takahashi Psychiatric Clinic, Ashiya, Hyogo Japan </aff></contrib-group><pub-date pub-type="epub"><day>10</day><month>12</month><year>2014</year></pub-date><pub-date pub-type="pmc-release"><day>10</day><month>12</month><year>2014</year></pub-date><pub-date pub-type="collection"><year>2014</year></pub-date><volume>14</volume><elocation-id>313</elocation-id><history><date date-type="received"><day>27</day><month>8</month><year>2014</year></date><date date-type="accepted"><day>27</day><month>8</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9; Katagiri et al; licensee BioMed Central Ltd. 2014</copyright-statement><license license-type="open-access"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><related-article related-article-type="corrected-article" id="d30e67" ext-link-type="doi" xlink:href="10.1186/1471-244X-13-20"/><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; The Author(s) 2014</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Correction</title><p>After the publication of this work [<xref ref-type="bibr" rid="CR1">1</xref>], we became aware that it contains inaccurate description. The correct description on page 5 was &#x0201c;At every timepoint, statistically significant differences were observed between IM olanzapine and IM placebo groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.01) (Figure one)&#x0201d;, and not &#x0201c;At every timepoint, statistically significant differences were observed between IM olanzapine and IM placebo groups (<italic>p</italic>&#x02009;&#x0003c;&#x02009;.001) (Figure one).&#x0201d; We regret any inconvenience that this inaccuracy might have caused.</p></sec></body><back><fn-group><fn><p>The online version of the original article can be found under doi:10.1186/1471-244X-13-20.</p></fn></fn-group><ref-list id="Bib1"><title>Reference</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katagiri</surname><given-names>H</given-names></name><name><surname>Fujikoshi</surname><given-names>S</given-names></name><name><surname>Suzuki</surname><given-names>T</given-names></name><name><surname>Fujita</surname><given-names>K</given-names></name><name><surname>Sugiyama</surname><given-names>N</given-names></name><name><surname>Takahashi</surname><given-names>M</given-names></name><name><surname>Gomez</surname><given-names>JC</given-names></name></person-group><article-title>A randomized, double-blind, placebo-controlled study of rapid-acting intramuscular olanzapine in Japanese patients for schizophrenia with acute agitation</article-title><source>BMC Psychiatry</source><year>2013</year><volume>13</volume><fpage>20</fpage><pub-id pub-id-type="doi">10.1186/1471-244X-13-20</pub-id><pub-id pub-id-type="pmid">23311957</pub-id></element-citation></ref></ref-list></back></article>